Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A Rogers

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Trends in Cardiovascular Medicine|July 1, 2015
MADIT-CRT and his many sonsPaul A Rogers, Daniel P Morin
The Journal of Biological Chemistry|February 5, 2002
Repair of nitric oxide-modified ferredoxin [2Fe-2S] cluster by cysteine desulfurase (IscS)Wenyu Yang, Paul A Rogers, Huangen Ding
American Journal of Physiology. Heart and Circulatory Physiology|June 27, 2006
Is there a need for another model on the pulsatile nature of coronary blood flow?Paul A Rogers, Takahiko Kiyooka, William M Chilian
DNA Repair|June 27, 2003
Reversible inactivation of E. coli endonuclease III via modification of its [4Fe-4S] cluster by nitric oxidePaul A Rogers, Lars Eide, Arne Klungland, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 31, 2006
H2O2 activates redox- and 4-aminopyridine-sensitive Kv channels in coronary vascular smooth musclePaul A Rogers, William M Chilian, Ian N Bratz, et al.
Mayo Clinic Proceedings|April 8, 2017
In Reply-Atrial Fibrillation: Interatrial Block May Be an Underdiagnosed and Easily Recognizable Risk FactorDaniel P Morin, Michael L Bernard, Christopher Madias, et al.
Mayo Clinic Proceedings|October 6, 2019
In reply-Atrial Fibrillation and Morbidity and Mortality in Stress-Induced CardiomyopathyDaniel P Morin, Michael L Bernard, Christopher Madias, et al.
Mayo Clinic Proceedings|November 10, 2016
The State of the Art: Atrial Fibrillation Epidemiology, Prevention, and TreatmentDaniel P Morin, Michael L Bernard, Christopher Madias, et al.
Current Problems in Cardiology|May 16, 2018
Current Evidence-Based Understanding of the Epidemiology, Prevention, and Treatment of Atrial FibrillationPaul A Rogers, Michael L Bernard, Christopher Madias, et al.
Journal of Cardiovascular Electrophysiology|January 9, 2020
Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery diseasePeter G Pantlin, Robert M Bober, Michael L Bernard, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Trends in Cardiovascular Medicine|July 1, 2015
MADIT-CRT and his many sonsPaul A Rogers, Daniel P Morin
The Journal of Biological Chemistry|February 5, 2002
Repair of nitric oxide-modified ferredoxin [2Fe-2S] cluster by cysteine desulfurase (IscS)Wenyu Yang, Paul A Rogers, Huangen Ding
American Journal of Physiology. Heart and Circulatory Physiology|June 27, 2006
Is there a need for another model on the pulsatile nature of coronary blood flow?Paul A Rogers, Takahiko Kiyooka, William M Chilian
DNA Repair|June 27, 2003
Reversible inactivation of E. coli endonuclease III via modification of its [4Fe-4S] cluster by nitric oxidePaul A Rogers, Lars Eide, Arne Klungland, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 31, 2006
H2O2 activates redox- and 4-aminopyridine-sensitive Kv channels in coronary vascular smooth musclePaul A Rogers, William M Chilian, Ian N Bratz, et al.
Mayo Clinic Proceedings|April 8, 2017
In Reply-Atrial Fibrillation: Interatrial Block May Be an Underdiagnosed and Easily Recognizable Risk FactorDaniel P Morin, Michael L Bernard, Christopher Madias, et al.
Mayo Clinic Proceedings|October 6, 2019
In reply-Atrial Fibrillation and Morbidity and Mortality in Stress-Induced CardiomyopathyDaniel P Morin, Michael L Bernard, Christopher Madias, et al.
Mayo Clinic Proceedings|November 10, 2016
The State of the Art: Atrial Fibrillation Epidemiology, Prevention, and TreatmentDaniel P Morin, Michael L Bernard, Christopher Madias, et al.
Current Problems in Cardiology|May 16, 2018
Current Evidence-Based Understanding of the Epidemiology, Prevention, and Treatment of Atrial FibrillationPaul A Rogers, Michael L Bernard, Christopher Madias, et al.
Journal of Cardiovascular Electrophysiology|January 9, 2020
Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery diseasePeter G Pantlin, Robert M Bober, Michael L Bernard, et al.
Pageof 3